Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116256554 | 11625655 | 4 | F | 201507 | 20160805 | 20151013 | 20160811 | EXP | GB-PFIZER INC-2015336943 | PFIZER | 69.00 | YR | M | Y | 0.00000 | 20160811 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116256554 | 11625655 | 1 | PS | RAPAMUNE | SIROLIMUS | 1 | Oral | 1 MG, UNK | Y | 21110 | 1 | MG | TABLET | ||||||
| 116256554 | 11625655 | 2 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 2 MG, UNK | Y | 21110 | 2 | MG | TABLET | ||||||
| 116256554 | 11625655 | 3 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 3 MG, 1X/DAY | Y | 21110 | 3 | MG | TABLET | QD | |||||
| 116256554 | 11625655 | 4 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 2.5 MG, 1X/DAY | Y | 21110 | 2.5 | MG | TABLET | QD | |||||
| 116256554 | 11625655 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 116256554 | 11625655 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | 0 | |||||||||||
| 116256554 | 11625655 | 7 | C | LOSARTAN. | LOSARTAN | 1 | UNK | 0 | |||||||||||
| 116256554 | 11625655 | 8 | C | LOSARTAN. | LOSARTAN | 1 | UNK | 0 | |||||||||||
| 116256554 | 11625655 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 75 MG, UNK | 0 | 75 | MG | |||||||||
| 116256554 | 11625655 | 10 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 116256554 | 11625655 | 11 | C | NEORAL | CYCLOSPORINE | 1 | 150 MG, UNK | 0 | 150 | MG | |||||||||
| 116256554 | 11625655 | 12 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 116256554 | 11625655 | 13 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116256554 | 11625655 | 1 | Immunosuppression |
| 116256554 | 11625655 | 2 | Renal transplant |
| 116256554 | 11625655 | 5 | Hypercholesterolaemia |
| 116256554 | 11625655 | 7 | Hypertension |
| 116256554 | 11625655 | 9 | Anticoagulant therapy |
| 116256554 | 11625655 | 11 | Renal transplant |
| 116256554 | 11625655 | 12 | Steroid therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116256554 | 11625655 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116256554 | 11625655 | Impaired healing | |
| 116256554 | 11625655 | Localised infection | |
| 116256554 | 11625655 | Skin ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116256554 | 11625655 | 3 | 201506 | 201603 | 0 | |
| 116256554 | 11625655 | 4 | 20160208 | 20160622 | 0 | |
| 116256554 | 11625655 | 5 | 2001 | 0 | ||
| 116256554 | 11625655 | 6 | 2013 | 0 | ||
| 116256554 | 11625655 | 7 | 2014 | 0 | ||
| 116256554 | 11625655 | 8 | 2015 | 0 | ||
| 116256554 | 11625655 | 9 | 1996 | 0 | ||
| 116256554 | 11625655 | 10 | 2013 | 0 | ||
| 116256554 | 11625655 | 11 | 1993 | 0 | ||
| 116256554 | 11625655 | 12 | 2015 | 0 | ||
| 116256554 | 11625655 | 13 | 1992 | 0 |